102 Oncology journals listed in the Directory of Open Access Journals with at least 10 papers in 2025. DOAJ is an independent, openly published list of open-access journals that meet its criteria.
As of 28 October 2026. From OpenAlex, Crossref and DOAJ. ORBIT Tier is our own ranking within a field, not a Scopus or Web of Science quartile.
| Journal | ISSN | Papers in 2025 | ORBIT Tier | Fee to publish | Open access | DOAJ | Country |
|---|---|---|---|---|---|---|---|
| Frontiers in Oncology | 2234-943X | 4,576 | 1 | ≈ ₹3,54,086 to publish | Yes | Yes | Switzerland |
| Discover Oncology | 2730-6011 | 2,542 | 1 | ≈ ₹2,07,273 to publish | Yes | Yes | United States |
| Journal of Translational Medicine | 1479-5876 | 1,581 | 1 | ≈ ₹3,48,928 to publish | Yes | Yes | United Kingdom |
| Journal of Inflammation Research | 1178-7031 | 1,172 | 1 | ≈ ₹4,07,130 to publish | Yes | Yes | New Zealand |
| Cancer Medicine | 2045-7634 | 1,016 | 1 | ≈ ₹4,68,388 to publish | Yes | Yes | United Kingdom |
| Current Oncology | 1198-0052 | 711 | 1 | ≈ ₹2,47,298 to publish | Yes | Yes | Canada |
| Journal for ImmunoTherapy of Cancer | 2051-1426 | 704 | 1 | ≈ ₹2,97,917 to publish | Yes | Yes | United Kingdom |
| International Journal of General Medicine | 1178-7074 | 624 | 1 | ≈ ₹3,71,318 to publish | Yes | Yes | New Zealand |
| The Oncologist | 1083-7159 | 573 | 1 | ≈ ₹3,45,684 to publish | Yes | Yes | United Kingdom |
| MedComm | 2688-2663 | 533 | 1 | ≈ ₹3,62,836 to publish | Yes | Yes | China |
| Asian Pacific Journal of Cancer Prevention | 1513-7368 | 532 | 1 | ≈ ₹37,697 to publish | Yes | Yes | Iran |
| EJC Skin Cancer | 2772-6118 | 494 | 3 | ≈ ₹1,10,264 to publish | Yes | Yes | |
| Cell Reports Medicine | 2666-3791 | 455 | 1 | ≈ ₹5,45,668 to publish | Yes | Yes | United States |
| Clinical and Translational Medicine | 2001-1326 | 416 | 1 | ≈ ₹3,43,045 to publish | Yes | Yes | United States |
| Immuno-Oncology Technology | 2590-0188 | 407 | 2 | ≈ ₹3,28,908 to publish | Yes | Yes | United Kingdom |
| Frontiers in Bioscience-Landmark | 2768-6698 | 380 | 1 | ≈ ₹2,82,729 to publish | Yes | Yes | Singapore |
| Translational Oncology | 1936-5233 | 378 | 1 | ≈ ₹3,65,663 to publish | Yes | Yes | United States |
| Cancer Science | 1347-9032 | 345 | 1 | ≈ ₹2,44,770 to publish | Yes | Yes | Japan |
| Therapeutic Advances in Medical Oncology | 1758-8340 | 279 | 1 | ≈ ₹2,63,881 to publish | Yes | Yes | United Kingdom |
| JCO Global Oncology | 2687-8941 | 274 | 1 | ≈ ₹2,32,969 to publish | Yes | Yes | United States |
| Cancer Control | 1073-2748 | 245 | 1 | ≈ ₹2,49,744 to publish | Yes | Yes | United States |
| ecancermedicalscience | 1754-6605 | 228 | 1 | ≈ ₹1,24,651 to publish | Yes | Yes | United Kingdom |
| Revista Brasileira de Cancerologia | 0034-7116 | 224 | 2 | Free to publish — per DOAJ | Yes | Yes | Brazil |
| Biomolecules and Biomedicine | 2831-0896 | 214 | 1 | ≈ ₹1,24,468 to publish | Yes | Yes | Bosnia & Herzegovina |
| Cancer Treatment and Research Communications | 2468-2942 | 210 | 1 | ≈ ₹2,77,075 to publish | Yes | Yes | United States |
| Cell Proliferation | 0960-7722 | 208 | 1 | ≈ ₹3,22,888 to publish | Yes | Yes | United Kingdom |
| Cancer Research Communications | 2767-9764 | 194 | 1 | ≈ ₹2,40,320 to publish | Yes | Yes | United States |
| Asia-Pacific Journal of Oncology Nursing | 2347-5625 | 193 | 1 | ≈ ₹2,33,723 to publish | Yes | Yes | India |
| EMBO Molecular Medicine | 1757-4676 | 180 | 1 | ≈ ₹7,32,019 to publish | Yes | Yes | United Kingdom |
| Biomarker Research | 2050-7771 | 166 | 1 | ≈ ₹3,32,262 to publish | Yes | Yes | United Kingdom |
| Molecular Biomedicine | 2662-8651 | 153 | 1 | ≈ ₹2,59,352 to publish | Yes | Yes | Singapore |
| JMIR Cancer | 2369-1999 | 151 | 1 | ≈ ₹1,87,073 to publish | Yes | Yes | Canada |
| Deutsches Ärzteblatt | 0012-1207 | 149 | 4 | Free to publish — per DOAJ | Yes | Yes | Germany |
| ESMO Gastrointestinal Oncology | 2949-8198 | 141 | 1 | ≈ ₹3,27,966 to publish | Yes | Yes | |
| Experimental Hematology and Oncology | 2162-3619 | 141 | 1 | ≈ ₹3,11,431 to publish | Yes | Yes | United Kingdom |
| Neoplasia | 1476-5586 | 137 | 1 | ≈ ₹3,57,181 to publish | Yes | Yes | United Kingdom |
| JNCI Cancer Spectrum | 2515-5091 | 123 | 1 | ≈ ₹1,83,868 to publish | Yes | Yes | United Kingdom |
| Cancer Biology and Medicine | 2095-3941 | 120 | 1 | ≈ ₹2,63,881 to publish | Yes | Yes | China |
| OncoImmunology | 2162-4011 | 120 | 1 | ≈ ₹3,11,002 to publish | Yes | Yes | United States |
| Cellular Oncology | 1570-5870 | 105 | 1 | ≈ ₹2,24,299 to publish | Yes | Yes | Netherlands |
| Oncology in Clinical Practice | 2450-1654 | 102 | 2 | Free to publish — per DOAJ | Yes | Yes | Poland |
| Indonesian Journal of Cancer | 1978-3744 | 94 | 3 | Free to publish — per DOAJ | Yes | Yes | Indonesia |
| ImmunoTargets and Therapy | 2253-1556 | 89 | 1 | ≈ ₹4,07,130 to publish | Yes | Yes | New Zealand |
| JCO oncology advances. | 2994-9750 | 89 | 1 | ≈ ₹3,58,124 to publish | Yes | Yes | United States |
| Cancer Biology & Therapy | 1538-4047 | 88 | 1 | ≈ ₹2,93,838 to publish | Yes | Yes | United States |
| Clinical and Translational Discovery | 2768-0622 | 86 | 1 | ≈ ₹2,12,481 to publish | Yes | Yes | Australia |
| BJC Reports | 2731-9377 | 85 | 1 | ≈ ₹2,38,521 to publish | Yes | Yes | |
| Chinese Clinical Oncology | 2304-3865 | 78 | 1 | ≈ ₹1,55,501 to publish | Yes | Yes | Hong Kong SAR China |
| Holistic Integrative Oncology | 2731-4529 | 78 | 1 | Free to publish — per DOAJ | Yes | Yes | |
| Journal of bone oncology | 2212-1366 | 76 | 1 | ≈ ₹3,19,484 to publish | Yes | Yes | Netherlands |
| BMJ Oncology | 2752-7948 | 73 | 1 | ≈ ₹2,97,917 to publish | Yes | Yes | |
| The Innovation Medicine | 2959-8745 | 72 | 1 | ≈ ₹2,82,729 to publish | Yes | Yes | |
| Exploration of Targeted Anti-tumor Therapy | 2692-3114 | 71 | 1 | ≈ ₹1,88,486 to publish | Yes | Yes | United States |
| Clinical Medicine Insights Oncology | 1179-5549 | 68 | 1 | ≈ ₹2,49,744 to publish | Yes | Yes | United Kingdom |
| Journal of the National Cancer Center | 2096-8663 | 68 | 1 | ≈ ₹2,54,456 to publish | Yes | Yes | China |
| Cancer Pathogenesis and Therapy | 2949-7132 | 67 | 1 | ≈ ₹2,54,456 to publish | Yes | Yes | |
| Asian Pacific Journal of Cancer Care | 2588-3682 | 66 | 2 | ≈ ₹28,273 to publish | Yes | Yes | Iran |
| Immuno | 2673-5601 | 65 | 1 | ≈ ₹1,12,408 to publish | Yes | Yes | Switzerland |
| Namık Kemal Tıp Dergisi | 2587-0262 | 63 | 2 | Free to publish — per DOAJ | Yes | Yes | Türkiye |
| Journal of Molecular Cell Biology | 1674-2788 | 61 | 1 | ≈ ₹2,57,284 to publish | Yes | Yes | United Kingdom |
| Journal of the Anus Rectum and Colon | 2432-3853 | 61 | 1 | ≈ ₹1,17,805 to publish | Yes | Yes | Japan |
| Cancer Innovation | 2770-9183 | 59 | 1 | ≈ ₹2,54,456 to publish | Yes | Yes | |
| Cancer Research Statistics and Treatment | 2590-3225 | 59 | 2 | Free to publish — per DOAJ | Yes | Yes | India |
| Academia oncology. | 2998-7741 | 58 | 2 | ≈ ₹1,88,486 to publish | Yes | Yes | United States |
| Medical Studies | 1899-1874 | 56 | 3 | ≈ ₹21,250 to publish | Yes | Yes | Poland |
| Onco | 2673-7523 | 53 | 1 | ≈ ₹1,12,408 to publish | Yes | Yes | Switzerland |
| MedComm – Oncology | 2769-6448 | 51 | 1 | ≈ ₹2,45,032 to publish | Yes | Yes | |
| Oncogenesis | 2157-9024 | 51 | 1 | ≈ ₹3,73,925 to publish | Yes | Yes | United States |
| Cerrahpasa Medical Journal | 2687-1904 | 50 | 3 | Free to publish — per DOAJ | Yes | Yes | Türkiye |
| Lymphatics | 2813-3307 | 49 | 2 | ≈ ₹1,12,408 to publish | Yes | Yes | |
| Współczesna Onkologia | 1428-2526 | 48 | 2 | ≈ ₹38,959 to publish | Yes | Yes | Poland |
| Basic & Clinical Cancer Research | 2228-5466 | 46 | 3 | Free to publish — per DOAJ | Yes | Yes | Iran |
| Clinical Surgical Oncology | 2773-160X | 45 | 2 | ≈ ₹1,88,486 to publish | Yes | Yes | |
| Journal of Mind and Medical Sciences | 2392-7674 | 45 | 1 | ≈ ₹1,34,890 to publish | Yes | Yes | Romania |
| MedComm – Future Medicine | 2769-6456 | 44 | 1 | ≈ ₹2,34,771 to publish | Yes | Yes | |
| Precision Clinical Medicine | 2096-5303 | 40 | 1 | ≈ ₹1,88,486 to publish | Yes | Yes | United Kingdom |
| Journal of Pancreatology | 2096-5664 | 39 | 2 | Free to publish — per DOAJ | Yes | Yes | China |
| Advances in Cancer Biology - Metastasis | 2667-3940 | 35 | 1 | ≈ ₹2,90,269 to publish | Yes | Yes | Netherlands |
| Medicine Plus | 2950-3477 | 33 | 1 | ≈ ₹94,243 to publish | Yes | Yes | |
| Journal of Psychosocial Oncology Research and Practice | 2637-5974 | 32 | 2 | ≈ ₹1,13,092 to publish | Yes | Yes | United States |
| Frontiers in Chemical Biology | 2813-530X | 31 | 1 | ≈ ₹2,19,196 to publish | Yes | Yes | |
| Journal of Immunotherapy and Precision Oncology | 2590-017X | 30 | 1 | ≈ ₹2,26,183 to publish | Yes | Yes | United States |
| South Russian Journal of Cancer | 2686-9039 | 30 | 2 | Free to publish — per DOAJ | Yes | Yes | Russia |
| Blood Immunology & Cellular Therapy | 3050-5976 | 29 | 2 | ≈ ₹2,82,729 to publish | Yes | Yes | |
| Colorectal Cancer | 1758-194X | 29 | 1 | ≈ ₹2,11,026 to publish | Yes | Yes | United Kingdom |
| Cell investigation. | 3050-5380 | 28 | 1 | ≈ ₹2,35,608 to publish | Yes | Yes | Netherlands |
| Bioinorganic Chemistry and Applications | 1565-3633 | 27 | 1 | ≈ ₹1,68,695 to publish | Yes | Yes | Egypt |
| Immunotherapy Advances | 2732-4303 | 27 | 1 | ≈ ₹2,74,856 to publish | Yes | Yes | United Kingdom |
| Oncología (Ecuador) | 1390-0110 | 27 | 4 | Free to publish — per DOAJ | Yes | Yes | Ecuador |
| Clinical Cancer Bulletin | 2791-3937 | 24 | 1 | Free to publish — per DOAJ | Yes | Yes | |
| South African Journal of Oncology | 2518-8704 | 22 | 2 | ≈ ₹57,112 to publish | Yes | Yes | South Africa |
| Gastrointestinal Tumors | 2296-3766 | 19 | 2 | ≈ ₹1,41,365 to publish | Yes | Yes | Switzerland |
| Korean Journal of Clinical Oncology | 1738-8082 | 18 | 1 | Free to publish — per DOAJ | Yes | Yes | South Korea |
| Revista de Epidemiologia e Saúde Pública - RESP | 2965-3827 | 18 | 3 | ≈ ₹4,992 to publish | Yes | Yes | Brazil |
| Frontiers in Cancer Control and Society | 2813-835X | 17 | 1 | ≈ ₹2,19,196 to publish | Yes | Yes | |
| Health Psychology Open | 2055-1029 | 17 | 1 | ≈ ₹1,88,486 to publish | Yes | Yes | United Kingdom |
| Journal of Skin Cancer | 2090-2905 | 15 | 1 | ≈ ₹1,03,667 to publish | Yes | Yes | United Kingdom |
| Advances in Modern Biomedicine | 2982-3870 | 14 | 2 | ≈ ₹4,712 to publish | Yes | Yes | Malaysia |
| Melanoma Management | 2045-0885 | 14 | 1 | ≈ ₹1,33,354 to publish | Yes | Yes | United Kingdom |
| Cancer Survivorship Research & Care | 2835-2610 | 13 | 2 | ≈ ₹1,49,847 to publish | Yes | Yes |
The first 100 of 102 journals, by papers published in 2025. The rest load in the browser, with search, sort and filters.